» Articles » PMID: 31947642

Effect of α-Bisabolol and Its β-Cyclodextrin Complex As TetK and NorA Efflux Pump Inhibitors in Strains

Abstract

Efflux pumps are proteins present in the plasma membrane of bacteria, which transport antibiotics and other compounds into the extracellular medium, conferring resistance. The discovery of natural efflux pump inhibitors is a promising alternative. α-Bisabolol is a sesquiterpene isolated from several plants such as L. and has important properties such as antibacterial and anti-inflammatory activity. Currently, the formation of inclusion complexes with β-Cyclodextrin has been used for improving the physicochemical characteristics of the host molecule. This study evaluated the effect of α-Bisabolol, in isolation and in complexation with β-Cyclodextrin, as TetK and NorA efflux pump inhibitors in strains. The minimum inhibitory concentration (MIC) was determined. Subsequently, inhibitory activity over the pumps was observed by an MIC reduction for the antibiotics, by using subinhibitory concentrations (MIC/8) in combination with tetracycline and norfloxacin. The MIC of the compounds was ≥1024 μg/mL. α-Bisabolol potentiated the action of tetracycline and reduced the MIC of norfloxacin to a clinically relevant concentration. The complexed substance showed synergism however, the effect of the isolated α-Bisabolol was superior to the complex. These results indicate α-Bisabolol is a potential substance to be used as an efflux pump inhibitor.

Citing Articles

ADME/Tox study and the effect of β-Caryophyllene on the resistant strain of carrying the QacA/B efflux pump gene.

Almeida-Bezerra J, da Costa Silva J, Bezerra Morais-Braga M, da Cruz R, Alencar G, Alves D Toxicol Rep. 2025; 14:101929.

PMID: 39968054 PMC: 11833615. DOI: 10.1016/j.toxrep.2025.101929.


Synergistic Antibacterial Action of Norfloxacin-Encapsulated G4 Hydrogels: The Role of Boronic Acid and Cyclodextrin.

Sardaru M, Rosca I, Morariu S, Ursu E, Rotaru A Gels. 2025; 11(1).

PMID: 39852006 PMC: 11764500. DOI: 10.3390/gels11010035.


Spectroscopic Characterization and Biological Effects of 1-Oxo-bisabolone-rich Hutch. subsp. Essential Oil Against Viruses, Bacteria, and Spore Germination.

Castagliuolo G, DellAnnunziata F, Pio S, Di Napoli M, Troiano A, Antonini D Plants (Basel). 2025; 14(1.

PMID: 39795328 PMC: 11723130. DOI: 10.3390/plants14010068.


Combating multidrug-resistant (MDR) Staphylococcus aureus infection using terpene and its derivative.

Salikin N, Keong L, Azemin W, Philip N, Yusuf N, Daud S World J Microbiol Biotechnol. 2024; 40(12):402.

PMID: 39627623 DOI: 10.1007/s11274-024-04190-w.


Antibacterial and Inhibitory Activity of Nora and Mepa Efflux Pumps of Estragole Complexed to β-Cyclodextrin (ES/β-CD) In Vitro Against Bacteria, Molecular Docking and MPO-Based Pharmacokinetics Prediction.

da Costa R, Torres Pessoa R, Dos Santos Silva E, Araujo I, Goncalves S, Rocha J Pharmaceutics. 2024; 16(11).

PMID: 39598592 PMC: 11597315. DOI: 10.3390/pharmaceutics16111469.


References
1.
Rodrigues F, Colares A, de Fatima Alves Nonato C, Galvao-Rodrigues F, Mota M, Moraes Braga M . In vitro antimicrobial activity of the essential oil from Vanillosmopsis arborea Barker (Asteraceae) and its major constituent, α-bisabolol. Microb Pathog. 2018; 125:144-149. DOI: 10.1016/j.micpath.2018.09.024. View

2.
Marshall N, Piddock L . Antibacterial efflux systems. Microbiologia. 1997; 13(3):285-300. View

3.
Bhatia S, McGinty D, Letizia C, Api A . Fragrance material review on alpha-bisabolol. Food Chem Toxicol. 2008; 46 Suppl 11:S72-6. DOI: 10.1016/j.fct.2008.06.025. View

4.
Tegos G, Haynes M, Strouse J, Khan M, Bologa C, Oprea T . Microbial efflux pump inhibition: tactics and strategies. Curr Pharm Des. 2011; 17(13):1291-302. PMC: 3717411. DOI: 10.2174/138161211795703726. View

5.
Blair J, Piddock L . How to Measure Export via Bacterial Multidrug Resistance Efflux Pumps. mBio. 2016; 7(4). PMC: 4958252. DOI: 10.1128/mBio.00840-16. View